Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing the novel safeguarding role of Selenoprotein T in age-related myocardial left and right decline through the ferroptosis-mitochondrial axis.

Journal of translational medicine·2026
Same author

Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion.

Basic research in cardiology·2026
Same author

Oxidative Stress in Takotsubo Syndrome: Insights into Extracellular Vesicles and Their Potential Clinical Relevance.

Antioxidants (Basel, Switzerland)·2026
Same author

Insights in ischemia/reperfusion injury and cardioprotection: neglected and emerging pathways and therapeutic targets for a personalized therapy.

Basic research in cardiology·2026
Same author

NLRP3 inhibition protects human coronary endothelial cells from oxidative and lipotoxic stress.

Biochemical pharmacology·2025
Same author

Correction: IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): a small animal acute myocardial infarction randomized-controlled multicenter study on the effect of ischemic preconditioning.

Basic research in cardiology·2025

Related Experiment Video

Updated: Jun 10, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Cardiac postconditioning.

Pasquale Pagliaro, Claudia Penna

    Antioxidants & Redox Signaling
    |August 18, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Brief coronary occlusions during reperfusion, known as postconditioning, protect the heart from injury. This method limits infarct size and apoptosis, offering potential benefits for acute myocardial infarction patients.

    More Related Videos

    Pre-clinical Model of Cardiac Donation after Circulatory Death
    06:26

    Pre-clinical Model of Cardiac Donation after Circulatory Death

    Published on: August 2, 2019

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
    07:02

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

    Published on: September 9, 2020

    Related Experiment Videos

    Last Updated: Jun 10, 2026

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
    05:26

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

    Published on: May 28, 2019

    Pre-clinical Model of Cardiac Donation after Circulatory Death
    06:26

    Pre-clinical Model of Cardiac Donation after Circulatory Death

    Published on: August 2, 2019

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
    07:02

    Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

    Published on: September 9, 2020

    Area of Science:

    • Cardiovascular Medicine
    • Cellular Biology
    • Pharmacology

    Background:

    • Ischemia/reperfusion injury is a major concern in acute myocardial infarction, primarily occurring during early reperfusion.
    • Postconditioning (PostC), involving brief coronary occlusions at reperfusion onset, has emerged as a protective strategy.
    • Pharmacological postconditioning offers an alternative route to elicit similar cardioprotective effects.

    Discussion:

    • PostC significantly limits infarct size, apoptosis, endothelial dysfunction, neutrophil adherence, and arrhythmias.
    • The protective mechanisms involve signaling pathways like reperfusion injury salvage kinase (RISK) and survivor activating factor enhancement (SAFE).
    • Intracellular acidosis and early redox-sensitive mechanisms also contribute to PostC-induced protection, though receptor and pathway specifics remain debated.

    Key Insights:

    • Postconditioning converges on mitochondria, particularly the mitochondrial permeability transition pore (mPTP).
    • Signaling cascades triggered by PostC involve RISK and SAFE pathways, similar to preconditioning.
    • Early cellular events like acidosis and redox changes are crucial for PostC efficacy.

    Outlook:

    • Preliminary clinical data suggest benefits of targeting mPTP or RISK pathways in acute myocardial infarction.
    • Further research is needed to elucidate principal protective cascades and pathway interdependence.
    • Identifying optimal pharmacological agents and considering comorbidities are crucial for future clinical translation.